April 24 Cara Therapeutics Inc:
* Cara Therapeutics announces positive data from quantitative phase 1 trial measuring respiratory safety of I.V. CR845
* Cara Therapeutics-trial showing that I.V. CR845 did not significantly differ from placebo across 3 quantitative measures of respiratory drive in healthy individuals
* Cara Therapeutics - reported treatment-emergent adverse events were previously reported with CR845 administration; were mild, resolving without intervention Source text for Eikon: Further company coverage:
UPDATE 1-Tropical storm Cindy moves inland in Louisiana; one dead in Alabama
June 22 Tropical storm Cindy moved inland near the Louisiana-Texas border on Thursday morning, bringing heavy rainfall and life-threatening conditions over the northern Gulf Coast, the U.S. National Hurricane Center said.
BRIEF-Michelin unveils global reorganization project
* Michelin group presents its global reorganization project to better serve its customer